As of 2024-12-13, the EV/EBITDA ratio of Andlauer Healthcare Group Inc (AND.TO) is 9.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AND.TO's latest enterprise value is 1,799.39 mil CAD. AND.TO's TTM EBITDA according to its financial statements is 190.85 mil CAD. Dividing these 2 quantities gives us the above AND.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 9.4x | 9.0x |
| Forward P/E multiples | 8.3x - 9.1x | 8.7x |
| Fair Price | 21.09 - 42.84 | 31.51 |
| Upside | -50.9% - -0.3% | -26.7% |
| Date | EV/EBITDA |
| 2024-12-11 | 9.28 |
| 2024-12-10 | 9.28 |
| 2024-12-09 | 9.31 |
| 2024-12-06 | 9.28 |
| 2024-12-05 | 9.23 |
| 2024-12-04 | 9.24 |
| 2024-12-03 | 9.43 |
| 2024-12-02 | 9.45 |
| 2024-11-29 | 9.48 |
| 2024-11-28 | 9.45 |
| 2024-11-27 | 9.50 |
| 2024-11-26 | 9.52 |
| 2024-11-25 | 9.26 |
| 2024-11-22 | 9.39 |
| 2024-11-21 | 9.36 |
| 2024-11-20 | 9.39 |
| 2024-11-19 | 9.26 |
| 2024-11-18 | 9.24 |
| 2024-11-15 | 9.27 |
| 2024-11-14 | 9.43 |
| 2024-11-13 | 9.39 |
| 2024-11-12 | 9.52 |
| 2024-11-11 | 9.43 |
| 2024-11-08 | 9.43 |
| 2024-11-07 | 9.82 |
| 2024-11-06 | 9.60 |
| 2024-11-05 | 9.19 |
| 2024-11-04 | 9.17 |
| 2024-11-01 | 9.07 |
| 2024-10-31 | 9.04 |
| 2024-10-30 | 9.05 |
| 2024-10-29 | 9.04 |
| 2024-10-28 | 9.01 |
| 2024-10-25 | 8.93 |
| 2024-10-24 | 8.96 |
| 2024-10-23 | 8.93 |
| 2024-10-22 | 8.92 |
| 2024-10-21 | 8.93 |
| 2024-10-18 | 8.91 |
| 2024-10-17 | 9.10 |
| 2024-10-16 | 9.01 |
| 2024-10-15 | 8.70 |
| 2024-10-11 | 8.61 |
| 2024-10-10 | 8.53 |
| 2024-10-09 | 8.53 |
| 2024-10-08 | 8.50 |
| 2024-10-07 | 8.42 |
| 2024-10-04 | 8.44 |
| 2024-10-03 | 8.63 |
| 2024-10-02 | 8.56 |